Lipids and Cholesterol

Latest

Rheumatoid Arthritis Not as Likely to Increase CVD Risk as Diabetes

Rheumatoid Arthritis Not as Likely to Increase CVD Risk as Diabetes

Using both public and private health insurance claims data, investigators conducted a retrospective cohort study to assess cardiovascular risk in the setting of diabetes and rheumatoid arthritis.

No Cardiovascular Benefit With Fenofibrate in T2D and Hypertriglyceridemia

No Cardiovascular Benefit With Fenofibrate in T2D and Hypertriglyceridemia

Statins were associated with a reduction in mortality but there was no significant difference in the composite end point with fenofibrates alone or in combination with statins.

Effect of Fenofibrate Varies Widely in Type 2 Diabetes

Effect of Fenofibrate Varies Widely in Type 2 Diabetes

The method of individualized treatment effect prediction of fenofibrate on major cardiovascular events risk reduction in T2D can be used to guide clinical decision-making.

Lipid Metabolism Imbalance and Pathophysiology of Bipolar Disease

Lipid Metabolism Imbalance and Pathophysiology of Bipolar Disease

Abnormal ratios of omega-6 to omega-3 fatty acids were associated with the presence of bipolar disorder and the severity and duration of major depressive disorder.

Statins Beneficial for High-Risk Patients Despite Adverse Reactions

Statins Beneficial for High-Risk Patients Despite Adverse Reactions

From 25% to 50% of patients discontinue statins within 6 months to 1 year of starting, and the rate increases as high as 75% after 2 years.

FDA Approves Pitavastatin for Hyperlipidemia, Mixed Dyslipidemia

FDA Approves Pitavastatin for Hyperlipidemia, Mixed Dyslipidemia

Multiple clinical studies have examined the efficacy of pitavastatin.

Metabolic Concerns With Dutasteride Therapy for BPH

Metabolic Concerns With Dutasteride Therapy for BPH

Dutasteride therapy for benign prostatic hyperlasia has been linked to elevated HbA1c and LDL cholesterol.

Statin Intolerance Contributes to Higher Risk for MI and CHD

Statin Intolerance Contributes to Higher Risk for MI and CHD

Patients with statin intolerance had a 36% higher rate of recurrent MI compared to those with high statin adherence.

Effects of Sex-Dependent On-Treatment LDL Diferences on CVD Risk

Effects of Sex-Dependent On-Treatment LDL Diferences on CVD Risk

Women experienced the same CV benefits in statin trials, despite having slightly elevated on-treatment LDL cholesterol.

Incident CHD Risk Elevated With High Triglycerides, Low HDL

Incident CHD Risk Elevated With High Triglycerides, Low HDL

Risk of both ischemic stroke and coronary heart disease was elevated with high triglycerides and low high-density lipoprotein cholesterol.

Sign Up for Free e-Newsletters

CME Focus